pharmaceutical
Global campaign to reduce cholera deaths by 90%
October 4, 2017Medical Communications, Research and Development Cholera, WHO, biotech, drugs, pharma, pharmaceutical
A new campaign, launched by the WHO, has begun today to reduce deaths from cholera by 90% through to 2030. …
Shire takes fight to Allergan over dry-eye drug
October 4, 2017Research and Development Allergan, Restasis, Shire, biotech, drugs, pharma, pharmaceutical
It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid …
Bavarian Nordic seals $539 million vaccine deal
October 3, 2017Manufacturing and Production BARDA, Bavarian Nordic, biotech, drugs, pharma, pharmaceutical
Bavarian Nordic, a Danish biotech, has continued its partnership with the US government by agreeing a $539 million deal to …
FDA to expedite complex generic approvals to lower drug prices through competition
October 3, 2017Manufacturing and Production, Sales and Marketing Donald Trump, Drug pricing, FDA, generics, pharma, pharmaceutical
In the midst of ongoing discussions over drug pricing, the FDA has announced plans to facilitate accelerated access to generic …
‘Universal flu vaccine’ to be trialed this winter
October 3, 2017Manufacturing and Production, Medical Communications Flu virus, Vaccine, biotech, drugs, influenza, pharma, pharmaceutical
Researchers are enrolling 500 participants for the trial of a flu vaccine to protect the population against all strains of …
AstraZeneca Chairman wants three-year Brexit transition period
October 3, 2017Manufacturing and Production, Medical Communications AstraZeneca, biotech, brexit, drugs, pharma, pharmaceutical
The Chairman of AstraZeneca, Leif Johansson, revealed in no uncertain terms that his company would like there to be a …
Collaboration brings forward potential broad flu cure
October 2, 2017Research and Development, Sales and Marketing biotech, drugs, flu, influenza, pharma, pharmaceutical
A joint research effort between The Scripps Research Institute and Janssen has seen the development of a peptide that could …
FDA awards Roche priority review in HER2-positive breast cancer
October 2, 2017Sales and Marketing Cancer, FDA, Herceptin, Perjeta, Roche, breast cancer, pharma, pharmaceutical
Roche has revealed that its monoclonal antibody Perjeta (pertuzumab) has been awarded priority review by the FDA as an adjuvant …
CureTech reclaims rare disease drug from Pfizer for $20 million
October 2, 2017Sales and Marketing Clal Biotechnology, CureTech, Medivation, Pfizer, pharma, pharmaceutical
CureTech, a biotech firm owned by Clal Biotechnology Industries, is set to reclaim a drug it sold more than two …
Ablynx posts strong data on key drug, looks set for approval
October 2, 2017Research and Development, Sales and Marketing Ablynx, biotech, drugs, pharma, pharmaceutical
In a major success for the European biotech industry, Ablynx has revealed that it had met the primary and secondary …
Lilly reveals major senior leadership reshuffle
October 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, biotech, drugs, pharma, pharmaceutical
Eli Lilly revealed on 29 September that it would promote four staff members to senior staff positions, and two senior …
MSD pulls out of hep C space to Gilead’s relief
October 2, 2017Sales and Marketing MSD, biotech, drugs, hepatitis C, pharma, pharmaceutical
MSD, known as Merck in North America, has announced that it will curtail its attempts to make an impact in …
Gilead’s COO retires, shares take a dive
September 29, 2017Medical Communications Gilead, Kevin Young, biotech, drugs, pharma, pharmaceutical
Gilead has announced that Kevin Young, its Chief Operating Officer, is set to retire from the company in early 2018. …
Lilly receives FDA breast cancer pill approval, doubts remain
September 29, 2017Medical Communications, Sales and Marketing Eli Lilly, Verzenio, biotech, drugs, pharma, pharmaceutical
Eli Lilly has received an important approval for its breast cancer treatment, Verzenio. The drug will be the third to …
Five more biosimilar-free years for AbbVie’s megablockbuster
September 28, 2017Medical Communications, Sales and Marketing AbbVie, Amgen, Amjevita, Humira, biotech, drugs, pharma, pharmaceutical
Humira is the key drug for AbbVie, and one the company hopes it will be able to push into the …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
